母乳喂养
随机对照试验
荟萃分析
哺乳期
医学
相对风险
系统回顾
母乳喂养
家庭医学
梅德林
人口学
护理部
产科
怀孕
儿科
置信区间
内科学
生物
社会学
生物化学
遗传学
作者
Alicia Taylor,Brittany Howell,Kristen Romme,Zhiwei Gao,Hai Xuan Nguyen,Leigh Anne Newhook,Laurie Twells
标识
DOI:10.1177/08903344221099914
摘要
Background: The World Health Organization recommends lactation support to enhance the rates of exclusive breastfeeding. Access to in person lactation support may be limited due to scarcity of resources (e.g., healthcare professionals) and geography. Advances in technology have allowed lactation supports to be offered virtually through information and communication technologies (i.e., telephone, internet, and social media). Research Aims: To (1) critically review and (2) statistically analyze the effectiveness of virtual lactation support for postpartum mothers’ exclusive breastfeeding for up to 6 months. Methods: A systematic review and meta-analysis were conducted using PRISMA guidelines. Studies were included if they were (a) randomized controlled trials, (b) with a virtual lactation support intervention during the postpartum period, (c) reported on exclusive breastfeeding outcomes. Two reviewers independently assessed the risk of bias and extracted data. The prevalence of exclusive breastfeeding in each group and the total number of participants randomized for each group were entered into random-effects meta-analyses to calculate a pooled relative risk (RR) at three different time points (1, 4, and 6 months). The sample size was 19 randomized control trials. Results: Of the 19 studies, 16 (84.2%) were included in the meta-analysis ( n = 5,254). Virtual lactation support was found to be effective at increasing exclusive breastfeeding at 1 month (RR, 1.21; 95% CI [1.09, 1.35]; p < .001) and 6 months (RR, 1.87; 95% CI [1.30, 2.68]; p < .001). Conclusion: In this meta-analysis of randomized controlled trials comparing virtual lactation support with other postnatal maternity care, virtual lactation support was associated with increasing exclusive breastfeeding rates at 1 month and 6 months postpartum. The study protocol was registered (CRD42021256433) with PROSPERO
科研通智能强力驱动
Strongly Powered by AbleSci AI